MIRABEGRON PROLONGED RELEASE – 50 MG

Mirabegron ER 50 (Mirabegron 50mg) is a medication used to treat overactive bladder (OAB) symptoms like frequent urination, urgency, and incontinence.

It belongs to a class of drugs called beta-3 adrenergic agonists, which work by relaxing the bladder muscles, reducing urinary frequency and urgency.

Drug Class: Beta-3 Adrenergic Agonist

Indications: Overactive Bladder (OAB)

Active Ingredient: Mirabegron 50mg

Dosage Form: Extended-Release Tablet (ER)

Mechanism of Action: Stimulates beta-3 adrenergic receptors in the bladder, relaxing detrusor smooth muscle, and increasing bladder capacity.

Administration: Take orally, usually once daily with or without food.

Effectiveness: Improves OAB symptoms, reducing urinary frequency and urgency.

Side Effects: May include headache, hypertension, urinary tract infection, and constipation. Contraindications: Hypersensitivity to mirabegron, severe uncontrolled hypertension, severe hepatic impairment.

Precautions: Monitor blood pressure during treatment, caution in patients with severe renal impairment.

Interactions: May interact with CYP3A4 inhibitors/inducers, antimuscarinic agents, and digoxin.

Pregnancy/Breastfeeding: Use during pregnancy only if benefits outweigh risks, not recommended during breastfeeding. Storage: Store at room temperature away from moisture and heat. Mirabegron ER 50 provides effective relief for OAB symptoms with a convenient once-daily dosing regimen. However, it’s important to follow your healthcare provider’s instructions and report any adverse effects promptly.